Medical & Healthcare

Analysis on Blood Product Industry in China

China’s blood product industry demonstrated a good prospect in 2016. The National Institute for Control of Pharmaceutical Biological Products inspected more than 4000 lots of blood products in total, equivalent to approximately 59 million bottles, which exhibited an upward trend. The present Chinese market is dominated by domestic products, with imported products occupying less than 5% of market shares. The lack of raw materials has an impact on the blood products. In particular, the demand volume of human serum albumin is 50% higher than the supply volume, contributing to a…

Read More